Open original FDA record ↗Recall record
- FDA identifier
- Z-1513-2015
- Company in FDA record
- CSA Medical
- FDA classification date
- Apr 23, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
TruFreeze Console caused a higher rate of liquid nitrogen (cryogen) to be delivered and may cause: stricture,scarring, bradycardia, or pneumothorax
Source facts
- Action
- CSA Medical issued letter dated 3/25/15 advising users of the problem. Users provided with: The mitigations available to the active venting procedures coupled with the extremely unlikely probability of injury, rare risk, thus allowing the physician to continue with active venting procedures. In regards a passive venting procedure may not have sufficient mitigation to allow the physician to identify the potential hazard with sufficient time to preclude a potential for injury. Therefore, passive users will be instructed not to use the system until a software improvement is put into place. Additionally, no catheters or consoles will be shipped to passive venting users of truFreeze. A response form to be signed and returned confirming receipt of the notification.Questions contact: Stephen Mascioli, MD 781-538-4755 smascioli@csamedical.com.
- Initiated
- 2015-03-25
- Root cause
- Software design
- Terminated
- 2015-08-21
- Distribution
- Nationwide
- Recall number
- Z-1513-2015
- Recall status
- Terminated
- CDRH record ID
- 135174
- FDA classified
- 2015-04-23
- Recall event number
- 70851